Enliven Therapeutics, Inc.
ELVN· Nasdaq
Who holds Enliven Therapeutics, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| GSA Capital Partners LLP | 39.9K | New | $1.8K | 0.1% | Nov 16, 2026 |
| Rothschild Investment LLC | 36 | −12.2% | $1.7K | 0.1% | Nov 10, 2026 |
| Parkside Financial Bank & Trust | 35 | +133.3% | $1.6K | 0.1% | Oct 27, 2026 |
| Fortitude Family Office, LLC | 34 | New | $1.6K | 0.1% | Oct 14, 2026 |
| SBI Securities Co., Ltd. | 27 | −15.6% | $1.2K | 0% | Oct 22, 2026 |
| Handelsbanken Fonder AB | 17.3K | ±0% | $793 | 0.1% | Nov 9, 2026 |
| Parallel Advisors, LLC | 17 | ±0% | $779 | 0% | Nov 3, 2026 |
| BFC Planning, Inc. | 10 | New | $458 | 0% | Nov 13, 2026 |
| Jones Financial Companies LLLP | 10 | New | $448 | 0% | Nov 13, 2026 |
| Fifth Third Bancorp | 5 | +25.0% | $211 | 0% | Nov 5, 2026 |
| Acadian Asset Management LLC | 4.1K | New | $188 | 0.1% | Nov 9, 2026 |
| SJS Investment Consulting Inc. | 4 | New | $184 | 0% | Oct 26, 2026 |
| KBC Group NV | 1.8K | ±0% | $83 | 0.1% | Oct 22, 2026 |
| Smartleaf Asset Management LLC | 1 | ±0% | $47 | 0% | Nov 10, 2026 |
| FNY Investment Advisers, LLC | 1K | −60.0% | $45 | 0.1% | Oct 16, 2026 |
| Nomura Asset Management Co Ltd | 0 | ±0% | $0 | 0% | Nov 12, 2026 |